Prostate-specific antigen （PSA） velocity： a test of controversial benefit in the era of increased prostate cancer screening

Determining the need for prostate biopsy remains one of the most controversial questions in urology. Over the past 10 years, practice guidelines have changed dramatically, especially among asymptomatic men with low prostate-specific antigen （PSA） and negative digital rectal exam. Thompson et al.

Saved in:
Bibliographic Details
Published in亚洲男性学杂志：英文版 Vol. 13; no. 4; pp. 614 - 615
Main Author Michael S Borofsky Danil V Makarov
Format Journal Article
LanguageEnglish
Published 2011
Subjects
PSA
利益
前列腺癌
抗原
泌尿外科
测试
筛查
速度
Online AccessGet full text

Cover

More Information
Summary:Determining the need for prostate biopsy remains one of the most controversial questions in urology. Over the past 10 years, practice guidelines have changed dramatically, especially among asymptomatic men with low prostate-specific antigen （PSA） and negative digital rectal exam. Thompson et al.
Bibliography:Determining the need for prostate biopsy remains one of the most controversial questions in urology. Over the past 10 years, practice guidelines have changed dramatically, especially among asymptomatic men with low prostate-specific antigen （PSA） and negative digital rectal exam. Thompson et al.
31-1795/R
ISSN:1008-682X
1745-7262